Phase II Trial Evaluating Elimination of Radiation Therapy

Cancer of the Larynx Clinical Trial

Official title:
Phase II Trial Evaluating Elimination of Radiation Therapy To Pathological N0 Neck(s) With Intensity Modulated Postoperative Radiation Therapy

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to determine if reducing or eliminating radiation treatment to one or both sides of the neck where there is no evidence of cancer can help spare the side effects of radiation treatment for head and neck cancer. In this study, the investigators plan to reduce the amount of radiation treatment received to healthy tissue

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00593840
Study type	Interventional
Source	Washington University School of Medicine
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	April 11, 2007
Completion date	April 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00117572` - Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)	Phase 3
Not yet recruiting	`NCT01607138` - Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life	N/A
Recruiting	`NCT00970502` - Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer	Phase 1/Phase 2
Completed	`NCT00462735` - Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer	Phase 2